RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma

INTRODUCTION: Oncogenic RET tyrosine kinase gene fusions and activating mutations have recently been identified in lung cancers, prompting initiation of targeted therapy trials in this disease. Although RET point mutation has been identified as a driver of tumorigenesis in medullary thyroid carcinom...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Endocrinol Metab
Egile Nagusiak: Grubbs, Elizabeth G., Ng, Patrick Kwok-Shing, Bui, Jacquelin, Busaidy, Naifa L., Chen, Ken, Lee, Jeffrey E., Lu, Xinyan, Lu, Hengyu, Meric-Bernstam, Funda, Mills, Gordon B., Palmer, Gary, Perrier, Nancy D., Scott, Kenneth L., Shaw, Kenna R., Waguespack, Steven G., Williams, Michelle D., Yelensky, Roman, Cote, Gilbert J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Endocrine Society 2015
Gaiak:
Special Features
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4333032/
https://ncbi.nlm.nih.gov/pubmed/25546157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-4153
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak